SPONSOR
Dana-Farber Cancer Institute
Total Trials
13
Recruiting
13
Phases
Phase 1, Phase 2, EARLY_Phase 1
Conditions studied: Smoking CessationSmoking BehaviorsSmoking, TobaccoSmoking, CigaretteSmoking (Tobacco) AddictionGlioblastomaEsophageal CancerRadiotherapyMagnetic Resonance ImagingMRI
Dana-Farber Cancer Institute is a clinical research sponsor with 13 registered studies on ClinicalTrials.gov, of which 13 are actively recruiting participants. Research covers conditions including Smoking Cessation, Smoking Behaviors, Smoking, Tobacco, Smoking, Cigarette.
The trial portfolio spans Phase 1, Phase 2, EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Dana-Farber Cancer Institute
How many clinical trials has Dana-Farber Cancer Institute sponsored?
ClinicalMetric currently tracks 13 clinical trials sponsored by Dana-Farber Cancer Institute, of which 13 are actively recruiting participants. These trials cover conditions including Smoking Cessation, Smoking Behaviors, Smoking, Tobacco. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Dana-Farber Cancer Institute research focus on?
Dana-Farber Cancer Institute clinical trials span Smoking Cessation, Smoking Behaviors, Smoking, Tobacco, Smoking, Cigarette, Smoking (Tobacco) Addiction, and additional conditions. The research pipeline includes Phase 1, Phase 2, EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Dana-Farber Cancer Institute clinical trial?
To participate in a Dana-Farber Cancer Institute trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Dana-Farber Cancer Institute trials with current recruitment status updated daily.
Clinical Trials by Dana-Farber Cancer Institute
NCT06945120
Recruiting
ACT Lung Health Intervention: Phase Two
Smoking Cessation
NCT04188535
Recruiting
Serial MRI Scans During Radiation Therapy
Glioblastoma
NCT06152809 Phase 1
Recruiting
CIML NK Cells With Venetoclax for AML
Acute Myeloid Leukemia
NCT06439693 Phase 2
Recruiting
The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer
Breast Cancer Female
NCT06722014
Recruiting
Integrating Pain-CBT Into an mHealth Analgesic Support Intervention for Patients With Chronic Pain From Advanced Cancers
Pain
NCT06716580
Recruiting
EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations
Lung Cancer
NCT07397611 Phase 2
Recruiting
Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC
Renal Cell Carcinoma
NCT04678401 Phase 1
Recruiting
IS-free Treg HaploHCT
Stem Cell Transplant Complications
NCT06907797
Recruiting
Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing
Acute Leukemia
NCT03113643 Phase 1
Recruiting
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Acute Myeloid Leukemia
NCT05463796
Recruiting
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Cancer Risk
NCT03875716
Recruiting
Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma
Head and Neck Cancer
NCT06122896 EARLY_Phase 1
Recruiting
Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals
Pancreatic Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology